Alzheimer Disease
Showing NaN - NaN of 61
Alzheimer Trial in United States (Bryostatin 1, Placebo)
Active, not recruiting
- Alzheimer Disease
- Bryostatin 1
- Placebo
-
Colton, California
- +18 more
Mar 28, 2022
Alzheimer Trial in Worldwide (COR388 capsule, Placebo capsule)
Completed
- Alzheimer Disease
- COR388 capsule
- Placebo capsule
-
Phoenix, Arizona
- +92 more
Mar 8, 2022
Alzheimer Trial in Worldwide (neflamapimod, )
Alzheimer Trial in Canada, United States (Simufilam 100 mg oral tablet, Placebo)
Active, not recruiting
- Alzheimer Disease
- Simufilam 100 mg oral tablet
- Placebo
-
Gilbert, Arizona
- +16 more
Sep 27, 2021
Alzheimer Trial in United States (Placebo oral tablet, Simufilam 100 mg tablet, Simufilam 50 mg oral tablet)
Completed
- Alzheimer Disease
- Placebo oral tablet
- +2 more
-
Gilbert, Arizona
- +8 more
Sep 7, 2021
Late Onset Alzheimer's Disease
Recruiting
- Alzheimer Disease
- Blood Draw
- Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
-
Washington, District of Columbia
- +11 more
Aug 11, 2021
Longitudinal Cognitive Assessment by BoCA
Recruiting
- Alzheimer Disease
- +6 more
- Boston Cognitive Assessment (BoCA)
-
Miami, FloridaAndrey Vyshedskiy
Jul 19, 2021
Alzheimer, Mild to Moderate Alzheimer Trial in United States (GRF6019)
Completed
- Alzheimer Disease
- Mild to Moderate Alzheimer Disease
-
Lemon Grove, California
- +9 more
Jan 8, 2021
Alzheimer Trial in Worldwide (BI 425809 dose 1, BI 425809 dose 2, BI 425809 dose 3)
Completed
- Alzheimer Disease
- BI 425809 dose 1
- +4 more
-
Colton, California
- +94 more
Oct 16, 2020
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation,Psychomotor Trial in Australia, United States
Completed
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05
- +2 more
-
Phoenix, Arizona
- +61 more
Oct 7, 2020
Alzheimer Trial in Worldwide (lecozotan SR (SRA-333))
Completed
- Alzheimer Disease
- lecozotan SR (SRA-333)
-
Phoenix, Arizona
- +82 more
Jul 1, 2020
Alzheimer Trial in Canada, United States (Placebo Control, ELND005)
Alzheimer Trial in United States (Crenezumab dose level 1, Crenezumab dose level 2, Crenezumb dose level 3)
Completed
- Alzheimer Disease
- Crenezumab dose level 1
- +3 more
-
Phoenix, Arizona
- +12 more
Jul 23, 2019
Alzheimer, Cognition Disorders Trial in United States (florbetapir F 18 PET scan)
Completed
- Alzheimer Disease
- Cognition Disorders
- florbetapir F 18 PET scan
-
Glendale, Arizona
- +74 more
Oct 23, 2018
Dementia, Alzheimer Trial in United States (multicomponent psychosocial intervention, Control arm)
Completed
- Dementia
- Alzheimer Disease
- multicomponent psychosocial intervention
- Control arm
-
Birmingham, Alabama
- +4 more
Jan 4, 2016